Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avalo Therapeutics Inc (NQ: AVTX ) 8.992 -0.508 (-5.35%) Streaming Delayed Price Updated: 3:55 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 33,766 Open 9.440 Bid (Size) 8.800 (2) Ask (Size) 10.15 (3) Prev. Close 9.500 Today's Range 8.801 - 9.440 52wk Range 0.0333 - 34.46 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Avalo Announces Participation in September Investor Conferences September 04, 2024 From Avalo Therapeutics Via GlobeNewswire Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 03, 2024 Via Benzinga Performance YTD +3.23% +3.23% 1 Month +13.67% +13.67% 3 Month -26.66% -26.66% 6 Month -40.69% -40.69% 1 Year +7494.17% +7494.17% More News Read More AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024 August 12, 2024 Via InvestorPlace Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates August 12, 2024 From Avalo Therapeutics Via GlobeNewswire The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer July 16, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa July 09, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer June 24, 2024 From Avalo Therapeutics Via GlobeNewswire Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit June 17, 2024 From Avalo Therapeutics Via GlobeNewswire AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023 May 24, 2024 Via InvestorPlace AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024 May 13, 2024 Via InvestorPlace Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates May 13, 2024 From Avalo Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 29, 2024 Via Benzinga Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades April 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 02, 2024 Via Benzinga Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 02, 2024 Via Benzinga Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket April 02, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 02, 2024 Via InvestorPlace Avalo Therapeutics Appoints Biotech Leaders to Board of Directors April 02, 2024 From Avalo Therapeutics Via GlobeNewswire Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket April 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 01, 2024 Via InvestorPlace Avalo Reports 2023 Financial Results and Provides Business Updates March 29, 2024 From Avalo Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session March 29, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.